See also this year's filing and all EDGAR filings for this company.
PDF Report 0001135906_2013_Epirus_Biopharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Provectus Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001135906, Epirus Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 38,369,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,654,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,535,000 |
| 3 | remainder_Assets | 1,817,000 |
| 4 | LiabilitiesCurrent | 19,631,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,977,000 |
| 9 | ResearchAndDevelopmentExpense | 41,423,000 |
| 10 | remainder_Expenses | 6,718,000 |
| 11 | remainder_Revenues | 12,550,000 |
| 12 | remainder_NetIncome | 241,000 |
| 13 | remainder_ComprehensiveNetIncome | 18,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 61,375,000 |
| 1 | Liabilities | 19,631,000 |
| 2 | Expenses | 57,118,000 |
| 3 | Revenues | 12,550,000 |
| 4 | StockholdersEquity | 41,744,000 |
| 5 | NetIncome | -44,327,000 |
| 6 | ComprehensiveNetIncome | -44,318,000 |
| 7 | BaseVar | 75,466,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.15 |
| 9 | EconomicCapitalRatio | 2.42 |
Edgar->Model Mapping
Feature Distribution
Change over Time
